Latest news

Polydendritic Nano-Adjuvant

vaccines / 15/07/2020 07/08/2020

Perpetuum starts pre-clinical stage investigation of it’s proprietary Polydendritic Nano-Adjuvants for novel vaccination strategies.

nutraceuticals / 03/06/2020 06/08/2020

Perpetuum launches it’s new brand Ombium, a nutritional supplement line targeting metabolic syndrome risk factors.

cosmetic / 09/02/2020 06/08/2020

Perpetuum set to launch the world’s first acne treatment based on it’s recombinant bacteriophage endolysin technology

cosmetic / 03/03/2019 06/08/2020

Perpetuum opens new division in China for the sales of it’s cosmetic consumer brands throughout APAC.